Literature DB >> 16857475

Seven days of gamma-hydroxybutyrate (GHB) use produces severe withdrawal.

Eric Perez, Jason Chu, Theodore Bania.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16857475     DOI： 10.1016/j.annemergmed.2006.03.040

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN： 0196-0644            Impact factor:   5.721


× No keyword cloud information.
  5 in total

Review 1.  Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.

Authors:  Rama M Kamal; Martijn S van Noorden; Wim Wannet; Harmen Beurmanjer; Boukje A G Dijkstra; Arnt Schellekens
Journal:  CNS Drugs       Date:  2017-01       Impact factor: 5.749

2.  Baclofen and gamma-hydroxybutyrate withdrawal.

Authors:  Jennifer L LeTourneau; Daniel S Hagg; Stephen M Smith
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

3.  [Course and complications of GHB detoxification treatment: a 1-year case series].

Authors:  Peter Neu
Journal:  Nervenarzt       Date:  2019-05       Impact factor: 1.214

Review 4.  GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.

Authors:  Francesco P Busardò; Alan W Jones
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

Review 5.  Toxicological Characterization of GHB as a Performance-Enhancing Drug.

Authors:  Arianna Giorgetti; Francesco Paolo Busardò; Raffaele Giorgetti
Journal:  Front Psychiatry       Date:  2022-04-18       Impact factor: 5.435
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.